Sh-lincSCRG1 notably inhibited tumour growth, resulting in a significantly decreased tumour volume and weightafter the 10th day in the tumour xenograft mice compared to the sh-NC mice; however, in-miR26a substantially reversed the tumour suppressor effect of sh-lincSCRG1 (Fig. 7a-b). Here, SCRG1 is linked to neoplasm.